From Donor to Development: Minimizing Risks in the Cell Starting Materials Supply Chain
25 Sep 2024
Cell Therapy Development
![From Donor to Development: Minimizing Risks in the Cell Starting Materials Supply Chain](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/partners/BioIVT.png/fit-in/1500x9999/filters:no_upscale())
- Identify the key risks that impact supply chain and manufacturing processes.
- The essential components of a robust regulatory and manufacturing framework.
- Identify key attributes for HCT/Ps and ancillary source material providers.
Industry Expert